Pure Global
NCT06280222

The Effectiveness of Virtual Reality on Anxiety Reduction in Women Undergoing Elective Egg Cryopreservation.

Virtual Reality (VR)-Based Intervention to Improve Pre-operative Anxiety in Patients Undergoing Elective Oocyte Cryopreservation: a Randomized Clinical Trial
Hadassah Medical Organization·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anxiety
Drug/Device/Intervention
The VR instrument - Oculus Quest 2
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Hadassah Medical Organization
Location
Jerusalem, Israel
Timeline & enrollment
Phase
N/A
Start date
Nov 15, 2023
End date
Feb 01, 2025
Enrollment
30 participants
Primary outcome

Vital signs,Vital signs,VAS (visual-analogue scale),State and Trait Anxiety (STAI) Score

Summary

A randomized trial assessing the effectiveness of virtual reality exposure prior to an oocyte
 retrieval procedure in terms of anxiety level .

ICD-10 classifications
Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06280222
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06280222 through Pure Global AI's free database. This phase not specified trial is sponsored by Hadassah Medical Organization and is currently Recruiting. The study focuses on Anxiety. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.